EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight ...

J INTS BIO, Inc. announced that research findings on its investigational fourth-generation EGFR tyrosine kinase inhibitor (TKI), JIN-A02, have been published in Clinical Cancer Research, a leading ...

Heather Quintana Suchan, a mother and music industry professional living with stage 4 lung cancer, shared how her diagnosis ...

USC doctors say careful staging and tumor testing help younger patients choose surgery and targeted treatments based on their ...

As smoking rates fall, lung cancer in never-smokers (LCINS) represents an increasing share of lung cancer diagnoses. These cancers are frequently detected at a late stage, when they are less treatable ...

As smoking rates fall, lung cancer in never-smokers (LCINS) represents an increasing share of lung cancer diagnoses. These cancers are frequently ...

Continuous glucose monitoring, cancer diagnostics, wearables, sweat sensing, and environmental/food safety - plus AI trends.

Identifying population-based eGFR distributions may help to identify patients at risk for developing chronic kidney disease earlier, according to study data published in Kidney International. More ...

Scientists are testing an entirely new way to fight heart disease: whether gene editing might offer a one-time fix for high ...

Liquid biopsy encompasses a variety of molecular approaches to detect circulating tumor DNA (ctDNA) and has become a powerful tool in the diagnosis and treatment of solid tumors. Current applications ...

Two companies show hints that switching off certain genes could dramatically lower cholest ...

Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved ...